Document ID: chunk:federal_register_of_legislation:F2017C00863:schedule:1:p2
Version: federal_register_of_legislation:F2017C00863
Segment Type: schedule
Provision Reference: sch 1 (pt 2/3)
Character Range: 6101–9607

severe traumatic brain injury before the clinical onset of optochiasmatic arachnoiditis;

         (5)          undergoing a course of therapeutic radiation for cancer, where the optic chiasm was in the field of radiation, before the clinical onset of optochiasmatic arachnoiditis;

         (6)          having received a cumulative equivalent dose of at least 20 sieverts of ionising radiation to the region of the optic chiasm before the clinical onset of optochiasmatic arachnoiditis;

            Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.

         (7)          having sarcoidosis or multiple sclerosis, involving inflammation of the leptomeninges surrounding the optic chiasm, before the clinical onset of optochiasmatic arachnoiditis;

            Note: leptomeninges is defined in the Schedule 1 - Dictionary.

         (8)          having an intrathecal myelogram or intrathecal treatment with a substance from the specified list of substances before the clinical onset of optochiasmatic arachnoiditis;

            Note: specified list of substances is defined in the Schedule 1 - Dictionary.

         (9)          having a bacterial, fungal or parasitic infection involving the leptomeninges surrounding the optic chiasm or intracranial optic nerves before the clinical worsening of optochiasmatic arachnoiditis;

            Note: leptomeninges is defined in the Schedule 1 - Dictionary.

         (10)      having a subarachnoid haemorrhage or bleeding into the subarachnoid space before the clinical worsening of optochiasmatic arachnoiditis;

         (11)      having surgery to an area in close proximity to the optic chiasm before the clinical worsening of optochiasmatic arachnoiditis;

         (12)      having a moderate to severe traumatic brain injury before the clinical worsening of optochiasmatic arachnoiditis;

         (13)      undergoing a course of therapeutic radiation for cancer, where the optic chiasm was in the field of radiation, before the clinical worsening of optochiasmatic arachnoiditis;

         (14)      having received a cumulative equivalent dose of at least 20 sieverts of ionising radiation to the region of the optic chiasm before the clinical worsening of optochiasmatic arachnoiditis;

            Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.

         (15)      having sarcoidosis or multiple sclerosis, involving inflammation of the leptomeninges surrounding the optic chiasm, before the clinical worsening of optochiasmatic arachnoiditis;

            Note: leptomeninges is defined in the Schedule 1 - Dictionary.

         (16)      having an intrathecal myelogram or intrathecal treatment with a substance from the specified list of substances before the clinical worsening of optochiasmatic arachnoiditis;

            Note: specified list of substances is defined in the Schedule 1 - Dictionary.

         (17)      inability to obtain appropriate clinical management for optochiasmatic arachnoiditis.

      9               Relationship to service

         (1)          The existence in a person of any factor referred to in section 8, must be related to the relevant service rendered by the person.

         (2)          The factors set out in subsections 8(9) to 8(17) apply only to material contribution to, or aggravation of, optochiasmatic arachnoiditis where the person's optochiasmatic arachnoiditis was suffered or contracted before or during (but did not arise out